CASP3 gene expression and the role of caspase 3 in the pathogenesis of depressive disorders
Related Experiment Video
Updated: Jul 17, 2025

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
Katarzyna Bliźniewska-Kowalska1, Piotr Gałecki2, Janusz Szemraj3
1Department of Adult Psychiatry, Medical University of Lodz, Lodz, Poland. katarzyna.blizniewska-kowalska@umed.lodz.pl.
Background:
The aim of our study was to evaluate the expression of the CASP3 gene at both mRNA and protein levels in patients with depressive disorders and to determine the impact of caspase 3 in the pathogenesis of depression; METHODS: A total of 290 subjects, including 190 depressed patients and 100 healthy controls, participated in the study. Socio-demographic and clinical data were collected, and the severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Venous blood was collected and gene expression was evaluated using RT-PCR and ELISA at the mRNA and protein levels, respectively; RESULTS: The expression of the CASP3 gene was significantly lower in depressed patients compared to healthy controls at both the mRNA and protein levels. Additionally, a positive correlation was observed between CASP3 gene expression and disease duration as well as the number of depressive episodes; CONCLUSIONS: Further studies are needed to investigate the role of caspase 3 in depressive disorders.
Related Concept Videos
Caspases
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
The Extrinsic Apoptotic Pathway
G-protein Coupled Receptors
The Intrinsic Apoptotic Pathway
Depression: Overview

